共 50 条
- [33] Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis MEDICINA-LITHUANIA, 2024, 60 (03):
- [37] Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (08): : 785 - 796